Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cureus ; 16(2): e54562, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38516439

RESUMO

The aim of this meta-analysis was to scrutinize the prevalence, characteristics, and outcomes of obstructive sleep apnea (OSA) in individuals with ideopathic pulmonary fibrosis (IPF). We carried out this systematic review and meta-analysis in accordance with the guidelines outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Statement (PRISMA). Two independent researchers systematically searched major databases, including MEDLINE/PubMed, EMBASE, and the Cochrane Library, from January 1, 2000, until December 31, 2023. We included all studies involving adult patients (age >18 years) with IPF that assessed the prevalence and characteristics of OSA in IPF patients. A total of seven studies involving a pooled sample of 411 patients were included in this meta-analysis. The pooled prevalence of OSA among individuals with IPF was found to be 70% (95% CI: 59 to 82%). Individuals with OSA exhibited a significantly higher mean body mass index (BMI) compared to their counterparts. While individuals with both IPF and OSA exhibited higher scores on the Epworth Sleepiness Scale (ESS) compared to those with IPF alone, the OSA group also showed lower oxygen saturation during sleep in comparison to non-OSA patients. In summary, OSA is a prevalent coexisting condition among individuals with IPF. This presence could worsen the nighttime oxygen saturation. Consequently, there is a need for more extensive studies involving more uniform participant groups.

2.
Curr Probl Cardiol ; 48(11): 101981, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37473935

RESUMO

This review provides an updated overview of the efficacy and safety of pitavastatin in patients with impaired glucose tolerance (IGT). IGT is a prediabetic state characterized by elevated blood glucose levels that do not meet the criteria for diabetes. The review explores the potential benefits of pitavastatin in reducing cardiovascular risk and improving lipid profiles in individuals with IGT. It also examines the glycemic effects of pitavastatin, including its impact on fasting blood glucose levels, insulin sensitivity, and beta-cell function. The review highlights the need for individualized treatment approaches, taking into account the patient's overall cardiovascular risk profile and glycemic control needs. While pitavastatin has shown modest improvements in glycemic control, it is not a substitute for lifestyle modifications or standard antidiabetic medications. Future directions for research include long-term follow-up studies, mechanistic investigations, and comparative analyses to further understand the glycemic effects of pitavastatin in IGT. Overall, this narrative review provides valuable insights for healthcare professionals involved in the management of individuals with IGT, emphasizing the importance of a comprehensive approach to reduce cardiovascular risk and optimize glycemic control.


Assuntos
Diabetes Mellitus Tipo 2 , Diabetes Mellitus , Intolerância à Glucose , Estado Pré-Diabético , Humanos , Intolerância à Glucose/tratamento farmacológico , Glicemia/análise , Diabetes Mellitus/tratamento farmacológico , Diabetes Mellitus/epidemiologia
3.
Chemistry ; 28(61): e202202023, 2022 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-35984235

RESUMO

Simple synthetic modifications that tune the molecular structures, thereby the properties of the molecules, are of topical interest. Herein, we report the synthesis of two novel cationic rosaniline-based conjugated microporous polymers (CMPs) from identical monomers via simple acid modulation (Acetic acid and BF3 ⋅ Et2 O). The condensation reaction of rosaniline with 2,4,6-triformylphloroglucinol in acetic acid renders ß-ketoenamine-linked CMP (CMP-A) while changing the acid to BF3 ⋅ Et2 O, the linkages transform to enol and undergoes BF2 -complexation, leading to boranil CMP (CMP-B). BF2 -functionalities in boranil CMP significantly modified the optical and functional properties compared to ß-ketoenamine-linked CMP. The cationic-delocalization along with the extended π-delocalization supported by chromophoric BF2 -groups allow CMP-B to exhibit broad absorption spanning the visible to Near-Infrared region (NIR). The absorption red-edge of CMP-B appears around 1277 nm (optical band gap ∼1.58 eV) while CMP-A displays at 981 nm (optical band gap ∼1.83 eV). Most interestingly, as a photocatalyst, CMP-B catalyzes hydrogen evolution with a superior rate of 252 µmol g-1 over CMP-A (100 µmol g-1 ). It is about 2.5 times higher performance. The transient photocurrent measurements, electrochemical impedance data, and in-depth mott-Schottky analysis demonstrate that the BF2 -group in CMP-B generates photoinduced charge carriers and their migration towards the active sites for photocatalysis. These polymers show significant photocatalytic H2 generation without any supportive metal co-catalyst. The BF2 complexed building blocks are a unique class of metal-free photocatalysts for hydrogen evolution through green and cost-effective approach.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...